These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 33587395)
1. Does a Positive Response to Lithium Augmentation in Resistant Major Depression Indicate a Bipolar Disorder?: A Long-Term Follow-up Study. Birkenhager TK; Shapiro-Koss C; Kamperman AM J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):202-204. PubMed ID: 33587395 [No Abstract] [Full Text] [Related]
2. Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder. Bauer M; Dell'osso L; Kasper S; Pitchot W; Dencker Vansvik E; Köhler J; Jørgensen L; Montgomery SA J Affect Disord; 2013 Oct; 151(1):209-19. PubMed ID: 23810357 [TBL] [Abstract][Full Text] [Related]
3. Lithium in the treatment of major depressive disorder. Bschor T Drugs; 2014 Jun; 74(8):855-62. PubMed ID: 24825489 [TBL] [Abstract][Full Text] [Related]
4. Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial. Kok RM; Vink D; Heeren TJ; Nolen WA J Clin Psychiatry; 2007 Aug; 68(8):1177-85. PubMed ID: 17854241 [TBL] [Abstract][Full Text] [Related]
5. Prediction of an Optimal Dose of Lamotrigine for Augmentation Therapy in Treatment-Resistant Depressive Disorder From Plasma Lamotrigine Concentration at Week 2. Nakamura A; Mihara K; Nagai G; Kagawa S; Suzuki T; Nemoto K; Kondo T Ther Drug Monit; 2016 Jun; 38(3):379-82. PubMed ID: 26829597 [TBL] [Abstract][Full Text] [Related]
6. Clinical correlates of augmentation/combination treatment strategies in major depressive disorder. Dold M; Bartova L; Mendlewicz J; Souery D; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S Acta Psychiatr Scand; 2018 May; 137(5):401-412. PubMed ID: 29492960 [TBL] [Abstract][Full Text] [Related]
7. Electrocardiographic Changes During Initiation of Lithium Augmentation of Antidepressant Pharmacotherapy. Berger M; Kermer J; Behr J; Schulz-Menger J; Bilal S; Osterland SL; O'Malley G; Bschor T; Schlattmann P; Stamm T; Steinacher B; de Millas W; Richter C; Heinz A; Adli M; Buspavanich P; Ricken R J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):87-91. PubMed ID: 34854829 [TBL] [Abstract][Full Text] [Related]
8. The Concurrent Treatment With Intravenous Ketamine and an Irreversible Monoamine Oxidase Inhibitor for Treatment-Resistant Depression Without Hypertensive Crises. Wang JCC; Swainson J J Clin Psychopharmacol; 2020; 40(5):515-517. PubMed ID: 32740556 [No Abstract] [Full Text] [Related]